Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001013594-17-000438 0001035674 XXXXXXXX LIVE 4 Common Shares, no par value 06/13/2025 false 0000885590 071734107 Bausch Health Companies Inc. 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 Kelly Zelezen, Esq 212-986-6000 Kelly Zelezen, Esq. 500 Fifth Avenue New York NY 10110 0001035674 PAULSON & CO. INC. OO DE 32791702 0 32791702 0 32791702 N 8.9 OO Items #7, 9, and 11: See Note 1 to Item 5 below. Common Shares, no par value Bausch Health Companies Inc. 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 The following constitutes Amendment No. 4 to the Schedule 13D filed by the undersigned ("Amendment No. 4"). This Amendment No. 4 amends the Schedule 13D as specifically set forth herein. The aggregate percentage of Common Shares reported owned by the Reporting Person is based upon approximately 367,933,897 Common Shares outstanding as of February 14, 2025, which is the total number of Common Shares outstanding as disclosed on the Issuer's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 20, 2025. As of the date hereof, the Reporting Person may be deemed to have beneficially owned approximately 8.9% of the outstanding Common Shares. Number of Common Shares as to which Paulson has: (i) Sole power to vote or direct the vote: 32,791,702 (see Note 1). (ii) Shared power to vote or direct the vote: 0 (iii) Sole power to dispose or direct the disposition: 32,791,702 (see Note 1). (iv) Shared power to dispose or direct the disposition: 0 The transactions effected by the Reporting Person during the past 60 days are set forth on Exhibit 1 attached hereto. See Note 1. Not applicable. Note 1: Paulson furnishes investment advice to and manages the Funds. In its role as investment advisor, or manager, as the case may be, Paulson possesses voting and investment power over the securities of the Issuer described in this Schedule 13D that are owned by the Funds. The pecuniary interest of all securities reported in this Schedule 13D is owned by the Funds. Except for the purposes of determining beneficial ownership under Section 13(d) of the Securities Exchange Act of 1934, as amended, Paulson disclaims beneficial ownership of all securities reported in this Schedule 13D. For reporting purposes, the aggregate amount of Common Shares deemed to be beneficially owned by the Reporting Person is calculated based on an aggregate 32,791,702 Common Shares held by the Reporting Person as of the date hereof. EXhibit 1: Transactions in Securities PAULSON & CO. INC. /s/ Stuart L. Merzer Stuart L. Merzer, General Counsel & Chief Compliance Officer 06/17/2025